Absence of association between genetic variation of the β3-adrenergic receptor and metabolic phenotypes in Oji-Cree

Diabetes Care

Volumn 21, Issue 5, 1998, Pages 851-854

  Hegele, Robert A ^a   Harris, Stewart B ^b   Hanley, Anthony J G ^c   Azouz, Husain ^d   Connelly, Philip W ^d,e   Zinman, Bernard ^c,e  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR;

ADOLESCENT; ADULT; ALLELE; ARTICLE; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHENOTYPE; RECEPTOR DENSITY; SCHOOL CHILD;

ADIPOSE TISSUE; ADULT; ALLELES; AMERICAN NATIVE CONTINENTAL ANCESTRY GROUP; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; BODY CONSTITUTION; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INSULIN; MALE; MIDDLE AGED; ONTARIO; PHENOTYPE; RECEPTORS, ADRENERGIC, BETA; VARIATION (GENETICS);

EID: 0031735262     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.5.851     Document Type: Article

References (41)

1. Chagnon YC, Perusse L, Bouchard C: Familial aggregation of obesity, candidate genes and quantitative trait loci. Curr Opin Lipidol 8:205-211, 1997
2. Velho G, Froguel P: Genetic determinants of non-insulin-dependent diabetes: strategies and recent results. Diabet Med 23:7-17, 1996
3. Walston J, Silver K, Bogardus C, Knowler WC, Celi FS, Austin S, Manning B, Strosberg AD, Stem MP, Raben N: Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the β-3-adrenergic receptor gene. N Engl Med 333:343-347,1995
4. Widen E, Lehto M, Kanninen T, Walston J, Shuldiner AR, Groop LC: Association of a polymorphism in the β-3-adrenergic receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 333:348-351, 1995
5. Clement K, Vaisse C, Manning BSJ, Basdevant A, Guy-Grand B, Ruiz J, Silver KD, Shuldiner AR, Froguel P, Strosberg AD: Genetic variation in the β-3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity N Engl J Med 333:352-354,1995
6. Silver K, Walston J, WangY, Dowse G, Zimmet P, Shuldiner AR: Molecular scanning for mutations in the β-3-adrenergic receptor gene in Nauruans with obesity and non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 81:4155-4158,1996
7. Kurabayashi T, Carey DG, Morrison NA: The β-3-adrenergic receptor gene Trp64Arg mutation is overrepresented in obese women. Diabetes 45:1358-1363,1996
8. Gagnon J, Mauriege P, Roy S, Sjostrom D, Chagnon YC, Dionne FT, Oppert JM, Perusse L, Sjostrom L, Bouchard C: The Trp64Arg mutation of the β-3-adrenergic receptor gene has no effect on obesity phenotypes in the Quebec Family Study and Swedish Obese Subjects cohorts. J Clin Invest 98:2086-2093, 1996
9. Elbein SC, Huffman M, Barrett K, Wegner K, Miles C, Bachman K, Barkowitz D, Shuldiner AR, Leppert MF, Hasstedt S: Role of the β-3-adrenergic receptor locus in obesity and non-insulin-dependent diabetes among members of Caucasian families with a diabetic sibling pair. J Clin Endocrinol Metab 81:4422-4427, 1996
10. Clement K, Ruiz J, Cassard-Doulcier A-M, Bouillaud F, Ricquier D, Basdevant A, GuyGrand B, Froguel P: Additive effect of an A-G (-3826) variant of the uncoupling protein gene and the Trp64Arg mutation of the β-3-adrenergic receptor gene on weight gain in morbid obesity. Int J Obes 20:1062-1066, 1996
11. Fumeron F, Durack-Bown I, Betoulle D, Cassard-Doulcier A-M, Tuzet S, Bouillaud F, Melchior J-C, Ricquier D, Apfelbaum M: Polymorphisms of uncoupling protein, (UCP) and β-3-adrenoreceptor genes in obese people submitted to a low-calorie, diet. Int J Obes 20:1051-1054, 1996
12. Zhang Y, Watt N, Stratton IM, WarrenPerry MG, Orho M, Groop L, Turner RC:, UKPDS 19: heterogeneity in NIDDM: separate contributions of IRS-1 and β3-adrenergic receptor mutations to insulin resistance and obesity, respectively, with no evidence for glycogen synthase gene mutations. Diabetologia 39:1505-1511, 1996
13. 3adrenergic receptor gene in morbid obesity. Int J Obes 20:1055-1061,1996
14. Li LS, Luhnqvist F, Luthman H, Arner P: Phenotypic characterization of the Trp64Arg polymorphism in the β-3-adrenergic receptor gene in normal weight and obese subjects. Diabetologa 39:857-860,1996
15. Urhammer SA, Clausen JO, Hansen T, Pedersen O: Insulin sensitivity and body weight changes in young white carriers of the codon 64 amino acid polymorphism of the β-3-adrenergic receptor gene. Diabetes 45:1115-1120, 1996
16. Kadowaki H, Yasuda K, Iwamoto K, Otabe S, Shimokawa K, Silver K, Walston J, Yoshinaga H, Kosaka K, Yamada N: A mutation in the β-3-adrenergic receptor gene is associated with obesity and hyperinsulinaemia in Japanese subjects. Biochem Biophys. Res Commun 215:555-560, 1995
17. Fujisawa T, Ikegami H, Yamato E, Takekawa K, Nakagawa Y, Hamada Y, Oga T, Ueda H, Shintani M, Fukuda M, Ogihara T: Association of Trp64Arg mutation of the β-3adrenergic receptor with NIDDM and body weight gain. Diabetologia 39:349-352,1996
18. Yoshida T, Sakane N, Umekawa T, Sakai M, Takahashi T, Kondo M: Mutation of β-3adrenergic receptor gene and response to treatment of obesity. Lancet 346:1433-1434, 1995
19. Ueda K, Tanizawa Y, Oota Y, Inoue H, Kizuki N, Inoue H, Tsukuda K, Asano T, Oka Y: Prevalence of the Trp64Arg missense mutation of the β-3-adrenergic receptor gene in Japanese subjects. Metabolism 46:199-202, 1997
20. Harris SB, Gittelsohn J, Hanley AJG, Barnie A, Wolever TMS, Gao J, Logan A, Zinman B: The prevalence of NIDDM and associated risk factors in native Canadians. Diabetes Care 20:185-197, 1997
21. Regele RA, Harris SB, Hanley AJ, Sadikian S, Connelly PW, Zinman B: Genetic variation of intestinal fatty acid-binding protein associated with variation in body mass in aboriginal Canadians, J Clin Endocrinol Metab 81:4334-4337, 1996
22. Hegele RA, Connelly PW, Scherer SW, Hanley AJ, Harris SB, Tsui LC, Zinman B: Paraoxonase-2 gene (PON2) G148 variant associated with elevated fasting plasma glucose in non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 82:3373-3377, 1997
23. Hegele RA, Connelly PW, Scherer SW, Hanley AJ, Harris SB, Tsui LC, Zinman B: Paraoxonase-2 G148 variant in an aboriginal Canadian girl with non-insulin-dependent diabetes. Lancet 350:785, 1997
24. Hegele RA, Zinman B, Hanley AJ, Harris S, Connelly PW: A common mtDNA polymorphism associated with variation in plasma triglyceride concentration. Am J Hum Genet 60:1552-1555, 1997
25. Hegele RA, Connelly PW, Hanley AJ, Sun F, Harris SB, Zinman B: Common genomic variants associated with variation in plasma lipoproteins in young aboriginal Canadians. Arteriosder Thromb Vase Biol 17:1060-1066, 1997
26. Hegele RA, Harris SB, Hanley AJ, Sun F, Connelly PW, Zinman B: Angiotensinogen gene variation associated with variation in blood pressure in aboriginal Canadians. Hypertension 29:1073-1077,1997
27. Nunez C, Gallagher D, Russell-Aulet M, Heymsfield SB: Bioimpedance analysis of, body fat composition: a new measurement approach. Int J Obes 18:498, 1994
28. Kushner RF, Kunigk A, Alspaugh M, Andronis PT, Leitch CA, Schoeller DA: Validation of bioelectrical impedance analysis as a measurement of change in body composition in obesity. Am J Clin Nutr 52:219-223, 1990
29. World Health Organization: WHO Expert Committee on Diabetes Mellitus. Second Report. Geneva, World Health Org., 1980 (Tech. Rep. Ser., no. 646)
30. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
31. SAS Institute: SAS/STAT User's Guide for Personal Computers. Version 6 Edition. Cary, NC, SAS Institute, 1987
32. 3-adrenergic receptor-mediated lipolysis and oxygen consumption in brown adipocytes from cynomolgus monkeys. J Clin Endocrinol Metab 82:395-401, 1997
33. Strosberg AD: Structure, function, and regulation of the three β-adrenergic receptors. Obes Res 3:5015-5055,1995
34. 3adrenergic receptor does not relate to body weight in healthy, premenopausal women. Int J Obes Relat Metab Disord 21:826-829, 1997
35. 3-adrenergic receptor gene: lack of association with NIDDM and features of insulin resistance syndrome. Diabetes Care 20:1319-1323, 1997
36. Yuan X, Yamada K, Koyama K, Ichikawa F, Ishiyama S, Koyanagi A, Koyama W, Nonaka K: β-3-adrenergic receptor gene polymorphism is not a major genetic determinant of obesity and diabetes in Japanese general population. Diabetes Res Clin Pract 37:1-7, 1997
37. 3-adrenergic receptor gene and obesity in Japanese men: a longitudinal analysis. J Clin Endocrinol Metab 82:1284-1287, 1997
38. Hegele RA: The genetic basis of atherosclerosis, Int J Clin Lab Res 27:2-13, 1997
39. Sakane N, Yoshida T, Yoshioka K, Nakamura Y, Umekawa T, Kogure A, Takakura Y, Kondo M: β3-adrenoreceptor gene polymorphism: a newly identified risk factor for proliferative retinopathy in NIDDM patients. Diabetes 46:1633-1636, 1997
40. Candelore MR, Deng L, Tota LM, Kelly LJ, Cascieri MA, Strader CD: Pharmacological characterization of a recently described human β-3-adrenergic receptor mutant. Endocrinology 137:2638-2641, 1996
41. Silver K, Walston J, Plotnick L, Taylor SI, Kahn CR, Shuldiner AR: Molecular scanning of β-3-adrenergic receptor gene in total congenital lipoatrophic diabetes mellitus. J Clin Endocrinol Metab 82:3395-3398,1997